Partial adrenal suppression with prolonged use of depo-provera / Nur Aisyah Zainordin, Fatimah Zaherah Mohd Shah and Rohana Abdul Ghani.
A 49-year old patient presented with symptoms of adrenal suppression following an attempt to withdraw Depo-Provera or Depot Medroxyprogesterone Acetate (DMPA) injection. She had been receiving DMPA injections for the past 16 years for contraception. She was initially prescribed DMPA by her gynaecolo...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universiti Teknologi MARA Cawangan Selangor,
2019-06.
|
| Subjects: | |
| Online Access: | Get fulltext View Fulltext in UiTM IR |
| LEADER | 01638 am a22001933u 4500 | ||
|---|---|---|---|
| 001 | 30083 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Zainordin, Nur Aisyah |e author |
| 700 | 1 | 0 | |a Mohd Shah, Fatimah Zaherah |e author |
| 700 | 1 | 0 | |a Abdul Ghani, Rohana |e author |
| 245 | 0 | 0 | |a Partial adrenal suppression with prolonged use of depo-provera / Nur Aisyah Zainordin, Fatimah Zaherah Mohd Shah and Rohana Abdul Ghani. |
| 260 | |b Universiti Teknologi MARA Cawangan Selangor, |c 2019-06. | ||
| 856 | |z Get fulltext |u https://ir.uitm.edu.my/id/eprint/30083/1/AJ_NUR%20AISYAH%20ZAINORDIN%20JCHS%20B%2019.pdf | ||
| 856 | |z View Fulltext in UiTM IR |u https://ir.uitm.edu.my/id/eprint/30083/ | ||
| 520 | |a A 49-year old patient presented with symptoms of adrenal suppression following an attempt to withdraw Depo-Provera or Depot Medroxyprogesterone Acetate (DMPA) injection. She had been receiving DMPA injections for the past 16 years for contraception. She was initially prescribed DMPA by her gynaecologist but later on began obtaining the medication directly from a private pharmacy without prior consultation from her gynaecologist. Clinically, she had been experiencing significant weight gain and appeared cushingoid. Blood investigations confirmed partial adrenal suppression with presence of an adrenal incidentaloma. This case reports a known side effect of DMPA but occurring at a much lower dose than previously described. It also highlights the need to increase the awareness of the insidious side effect of DMPA and to avoid unsupervised use of the drug. | ||
| 546 | |a en | ||
| 650 | 0 | 4 | |a Cerebral cortex |
| 650 | 0 | 4 | |a Auditory cortex. Sensorimotor cortex |
| 655 | 7 | |a Article | |